Detalhe da pesquisa
1.
HUMANISE: Human-Inspired Smart Management, towards a Healthy and Safe Industrial Collaborative Robotics.
Sensors (Basel)
; 23(3)2023 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36772209
2.
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
Neurobiol Dis
; 121: 252-262, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296616
3.
Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation.
Front Pharmacol
; 13: 953652, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36133803
4.
The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats.
Br J Pharmacol
; 178(12): 2516-2532, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686657
5.
Analysis of Fine Motor Skills in Essential Tremor: Combining Neuroimaging and Handwriting Biomarkers for Early Management.
Front Hum Neurosci
; 15: 648573, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168544
6.
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata.
Br J Pharmacol
; 177(17): 3957-3974, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464686
7.
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers.
Front Neurosci
; 14: 590029, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154717
8.
Nanodelivery of therapeutic agents in Parkinson's disease.
Prog Brain Res
; 245: 263-279, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30961870
9.
Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease.
Int Rev Neurobiol
; 137: 99-122, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132545
10.
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease.
Int J Nanomedicine
; 9: 2677-87, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24920904
11.
In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease.
Eur J Pharm Biopharm
; 85(3 Pt B): 1183-90, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23639739